Vaccine development is the process of taking a new antigen or immunogen identified in the research process and producing a final vaccine - the safety and efficacy of which can be evaluated in pre-clinical and clinical studies.

Our vaccine development research tools and reference standards help to support the processes behind vaccine development and are designed to meet all quality and regulatory requirements.

We have a wide range of viral strains, all of which are integral to the process of vaccine production research and development, including coronavirus, influenza, Zika and others, as well as inactivated virus and cell lines validated for viral production.